Compare M Cash Integrasi Tbk. (MCAS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M Cash Integrasi Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? M Cash Integrasi Tbk. trades at Rp270 (market cap 246.49B, 2.01M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: M Cash Integrasi Tbk. is far larger — about 2.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MCAS | SCPI | |
|---|---|---|
Market Cap | 246.49B | 104.4B |
Volume | 2.01M | — |
Lot | 20.07K | — |
Turnover | 542.85M | — |
Average Price | 270.44 | — |
Value | 542.85M | — |
Indicative Equilibrium Price | 270 | — |
Indicative Equilibrium Volume | 62 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M Cash Integrasi Tbk.
PT M Cash Integrasi Tbk (the Company) was established based on Notarial Deed No. 1 of UkonKrisnajaya, S.H., Sp.N. dated June 1, 2010.
Read more on MCAS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
